Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.

Sexual activity in obese women improves after bariatric surgery

16 Dec 2019
Powering it through: Patients battling with obesity need more than just exercise and a healthy diet.

Bariatric surgery helps improve sexual activity in women with morbid obesity a year after the procedure, a recent study has found. The Incontinence Sexual Questionnaire-International Urogynecology Association–Revised (PISQ-IR) is a useful tool to measure sexual function in this population.

Researchers conducted a prospective, monocentric study on 54 women (median age, 42 years) who underwent bariatric surgery via sleeve gastrectomy or Roux-en-Y gastric bypass. Sexual activity, pelvic organ prolapse, anal incontinence, postoperative complications and total weight loss were among the study outcomes measured at the 1-year follow-up.

Fifty-one women were able to complete the follow-up questionnaire. Nine participants transitioned from being sexually inactive to being active 1 year after the procedure.

Eight women were sexually inactive before and after the procedure. In this group, PISQ-IR scores showed no significant change over time. In women who were sexually active for the entire study duration (n=34), PISQ-IR scores improved over time, particularly in the domains of arousal and global quality of life.

Moreover, at a threshold value of 13, a drop in body mass index 1 year after surgery correlated with better sexual function. When the magnitude of decrease was more than 13, more sexually active women showed improvements in PISQ-IR score.

“This is the first study using PISQ-IR questionnaire for sexual activity after bariatric surgery to our acquaintance,” said researchers. The present findings confirm the benefit of the procedure in terms of quality of life, with regard to sexual activity.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 31 Dec 2019
Adding the neuraminidase inhibitor oseltamivir to usual care speeds up recovery from influenza-like illness by a day compared with usual care alone, with even greater benefits seen in older, sicker patients with comorbidities, according to the ALIC4E study.
23 Dec 2019
At a Menarini-sponsored symposium held during the Asian Pacific Society Congress, renowned cardiologist Prof John Camm provided the latest evidence for chronic stable angina with or without concomitant diseases, with a special focus on the antianginal agent ranolazine and combination therapies. The event was chaired and moderated by Dr Dante Morales from the University of the Philippines College of Medicine.
Pearl Toh, 5 days ago
Obeticholic acid significantly improves fibrosis and disease activity in patients with nonalcoholic steatohepatitis (NASH), a chronic liver disease currently with no approved therapy, according to an interim analysis of the landmark REGENERATE* study.
6 days ago
Testosterone treatment may slightly improve sexual functioning and quality of life in men without underlying organic causes of hypogonadism, but it offers little to no benefit for other common symptoms of ageing, according to a study. In addition, long-term efficacy and safety of this therapy remain unknown.